期刊文献+

保阴煎联合西药治疗产科抗磷脂综合征阴虚血热型患者的临证经验 被引量:3

Clinical Experience of BaoYin Decoction Combined with Western Medicine in the Treatment of Yin Deficiency Blood Heat Type of Obstetric Antiphospholipid Syndrome
下载PDF
导出
摘要 文章介绍李淑萍教授运用保阴煎联合西药治疗产科抗磷脂综合征阴虚血热型患者的临证经验。李淑萍教授治疗上以清热养血,固冲安胎为基本治法,治以保阴煎联合西药提高患者早期妊娠成功率,降低妊娠丢失率。其疗效显著,可为临床免疫性复发性流产提供中西医治疗思路。 This paper introduces Professor Li Shuping's clinical experience in treating patients with yin deficiency blood heat of obstetric antiphospholipid syndrome by Bao Yin decoction combined with western medicine.Professor Li Shuping takes clearing heat and nourishing blood,solid washing and calming the fetus as the basic treatment method,and combines Bao Yin decoction with western medicine to improve the success rate of early pregnancy andreduce pregnancy loss rates.Its curative effect is significant,which provides the treatment idea of traditional Chinese and western medicine for clinical immune recurrent abortion.
作者 仲亚梅 李淑萍 ZHONG Yamei;LI Shuping(Nanjing University of Chinese Medicine,Nanjing 210023,China;Changzhou Hospital Affiliated to Nanjing University of Chinese Medicine,Changzhou 213000,China)
出处 《中国民族民间医药》 2021年第24期87-89,94,共4页 Chinese Journal of Ethnomedicine and Ethnopharmacy
基金 常州市高层次卫生人才项目:中医药对不孕及复发性流产的临床和实验研究(2016CZLJ031)。
关键词 产科抗磷脂综合征 复发性流产 阴虚血热型 保阴煎 Obstetric anti-phospholipid syndrome recurrent abortion yin deficiency blood heat type Bao Yin decoction
  • 相关文献

参考文献5

二级参考文献53

  • 1陈惠萍,胡峰.抗磷脂综合征肾损害[J].肾脏病与透析肾移植杂志,2004,13(5):490-492. 被引量:3
  • 2Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease ex- pression in a cohort of 1 000 patients[ J]. Arthritis Rheum, 2002, 46(4) : 1019 - 1027.
  • 3Tincani A, Bazzani C, Zingarelli S, et al. Lupus and the an- tiphospholipid syndrome in pregnancy and obstetrics : clinical char- acteristics, diagnosis, pathogenesis, and treatment I J]. Semin Thromb Hemost, 2008, 34 (3) : 267 -273.
  • 4Cervera R, Khamashta MA, Shoenfeld Y, et al. Morbidity and mortality in the antiphospholi-pid syndrome during a 5-year period : a multicentre prospective study of 1000 patients [ J ]. Ann Rheum Dis, 2009, 68(9) : 1428 -1432.
  • 5Galarza-Maldonado C, Kourilovitch MR, Perez-Fernandez OM, et al. Obstetric antiphospholipid syndrome [ J ]. Antoimmun Rev, 2012, 11 : 288 -295.
  • 6Farquharson RG, Quenby S, Greaves M. Antiphospholipid syn- drome in pregnancy: a randomized, controlled trial of treatment [J]. Obstet Gynecol, 2002, 100(4) : 408 -413.
  • 7Derksen RH, de Groot PG. The obstetric antiphospholipid syn- drome[ J ]. J Reprod Immunol, 2008, 77 ( 1 ) : 41 - 50.
  • 8Fouda UM, Sayed AM, Ramadan DI, et al. Efficacy and safety oftwo doses of low molecular weight heparin (enoxaparin) in preg- nant women with a history of recurrent abortion secondary to an- tiphospholipid syndrome[J]. J Obstet Gynaecol, 2010, 30 (8) : 842 - 846.
  • 9Ruffatti A, Tonello M, Cavazzana A, et al. Laboratory classifica- tion categories and pregnancy outcome in patients with primary an- tiphospholipid syndrome prescribed antithrombotic therapy [ J ]. Thromb Res, 2009, 123(3) : 482 -487.
  • 10Ruffatti A, Tonello M, Visentin MS, et al. Risk factors for preg- nancy failure in patients with anti-phospholipid syndrome treated with conventional therapies : a multicentre, case-control study [ J ]. Rheumatology (Oxford), 2011,50(9): 1684-1689.

共引文献281

同被引文献38

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部